These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15935319)

  • 1. Modeling drug detection and diagnosis with the 'drug evaluation and classification program'.
    Schechtman E; Shinar D
    Accid Anal Prev; 2005 Sep; 37(5):852-61. PubMed ID: 15935319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug identification performance on the basis of observable signs and symptoms.
    Shinar D; Schechtman E
    Accid Anal Prev; 2005 Sep; 37(5):843-51. PubMed ID: 15885613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward a more parsimonious approach to drug recognition expert evaluations.
    Porath-Waller AJ; Beirness DJ; Beasley EE
    Traffic Inj Prev; 2009 Dec; 10(6):513-8. PubMed ID: 19916120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory validation study of drug evaluation and classification program: alprazolam, d-amphetamine, codeine, and marijuana.
    Heishman SJ; Singleton EG; Crouch DJ
    J Anal Toxicol; 1998 Oct; 22(6):503-14. PubMed ID: 9788526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplifying the process for identifying drug combinations by drug recognition experts.
    Porath-Waller AJ; Beirness DJ
    Traffic Inj Prev; 2010 Oct; 11(5):453-9. PubMed ID: 20872299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Drug Evaluation Classification Program: using ocular and other signs to detect drug intoxication.
    Kosnoski EM; Yolton RL; Citek K; Hayes CE; Evans RB
    J Am Optom Assoc; 1998 Apr; 69(4):211-27. PubMed ID: 9585661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Drug Evaluation and Classification program: a critical review of the evidence.
    Beirness DJ; LeCavalier J; Singhal D
    Traffic Inj Prev; 2007 Dec; 8(4):368-76. PubMed ID: 17994490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing limits for driving under cannabis.
    Grotenhermen F; Leson G; Berghaus G; Drummer OH; Krüger HP; Longo M; Moskowitz H; Perrine B; Ramaekers JG; Smiley A; Tunbridge R
    Addiction; 2007 Dec; 102(12):1910-7. PubMed ID: 17916224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine and driving.
    Lemos NP
    Sci Justice; 2009 Dec; 49(4):247-9. PubMed ID: 20120602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An examination of the validity of the standardized field sobriety test in detecting drug impairment using data from the Drug Evaluation and Classification program.
    Porath-Waller AJ; Beirness DJ
    Traffic Inj Prev; 2014; 15(2):125-31. PubMed ID: 24345013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing cannabis-impaired driving: is there sufficient evidence for drug testing of drivers?
    Hall W; Homel R
    Addiction; 2007 Dec; 102(12):1918-9. PubMed ID: 18031427
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
    Crouch DJ; Walsh JM; Cangianelli L; Quintela O
    Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
    Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
    Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Referrals for psychiatric examination of driving ability - a comparison of illicit drugs and alcohol].
    Haberfellner EM
    Neuropsychiatr; 2008; 22(2):137-42. PubMed ID: 18606117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blind trials of an onsite saliva drug test for marijuana and opiates.
    Jehanli A; Brannan S; Moore L; Spiehler VR
    J Forensic Sci; 2001 Sep; 46(5):1214-20. PubMed ID: 11569567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roadside detection of impairment under the influence of ketamine--evaluation of ketamine impairment symptoms with reference to its concentration in oral fluid and urine.
    Cheng WC; Ng KM; Chan KK; Mok VK; Cheung BK
    Forensic Sci Int; 2007 Jul; 170(1):51-8. PubMed ID: 17046188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for toxicological investigation of drug impaired driving.
    Farrell LJ; Kerrigan S; Logan BK
    J Forensic Sci; 2007 Sep; 52(5):1214-8. PubMed ID: 17680796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of current clinical diagnosis in recreational drug-related attendance to the emergency department.
    West E; Cameron P; O'Reilly G; Drummer OH; Bystrzycki A
    Emerg Med Australas; 2008 Aug; 20(4):333-8. PubMed ID: 18782207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive traffic enforcement: a simple and effective injury prevention program.
    Davis JW; Bennink LD; Pepper DR; Parks SN; Lemaster DM; Townsend RN
    J Trauma; 2006 May; 60(5):972-6; discussion 976-7. PubMed ID: 16688057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.